Add BrightSurf on Google Email

Researchers find a treatment for deadly brain tumor

A new research at Rhode Island Hospital has identified a treatment for glioblastomas, a deadly brain tumor that offers a poor prognosis and relatively short life expectancy. Using a synthetic form of a naturally-occurring hormone combined with chemotherapy, researchers achieved a 25 percent cure rate in animal models.

SourceLifespan·JournalJournal of Oncology·DateJan 19, 2010

Autism linked with stress hormone levels

A study led by the University of Bath found that children with Asperger Syndrome do not experience a surge in cortisol levels after waking, which may contribute to their struggles with minor changes. The researchers believe this could help explain why individuals with AS have difficulties adapting to routine or environmental changes.

SourceUniversity of Bath·JournalPsychoneuroendocrinology·DateApr 2, 2009

Smoking during pregnancy may impair thyroid function of mom and fetus

A new study published in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism found that cigarette smoking during pregnancy is associated with changes in maternal thyroid hormone levels. Smoking-related changes in thyroid function extend to the fetus, potentially leading to impaired neuropsychological development.

SourceThe Endocrine Society·JournalThe Journal of Clinical Endocrinology & Metabolism·DateJan 13, 2009

Key to regulation of puberty discovered

Researchers at University of Cambridge identify Neurokinin B as critical part of control system that switches on human puberty, offering new treatments for sex hormone dependent diseases and contraception. The discovery also has implications for understanding normal regulation of key bodily functions.

SourceUniversity of Cambridge·JournalNature Genetics·DateDec 11, 2008

New biomarker for heart failure identified

Researchers have identified a new biomarker for heart failure, resistin, which can independently predict an individual's risk of developing the condition. Resistin levels were found to increase the risk of new-onset heart failure by 38% and were a stronger predictor than other inflammatory markers.

New hormone data can predict menopause within a year

Researchers at the University of Michigan found that declines in anti-Mullerian hormone (AMH) and inhibin B concentrations predict the time to menopause, while changes in follicle-stimulating hormone (FSH) stages identify different reproductive periods. This information can help women understand their biological clock and fertility.

SourceUniversity of Michigan·JournalThe Journal of Clinical Endocrinology & Metabolism·DateOct 27, 2008

Gut hormone makes food look even yummier

A new study found that ghrelin increases the response to food pictures in brain regions involved in reward and motivation, suggesting a link between pleasure signals and metabolic drives. The findings may have implications for treating obesity and could inform policies aimed at reducing fast food consumption.

SourceCell Press·JournalCell Metabolism·DateMay 6, 2008

Fat-cell hormone linked to kidney disease

Researchers at UC San Diego School of Medicine found that low levels of adiponectin, a hormone produced by fat cells, are linked to elevated albumin protein in the urine and increased inflammation in the kidney. The study suggests that supplementing with adiponectin or other therapies may help protect kidney function in obese patients.

SourceUniversity of California - San Diego·JournalJournal of Clinical Investigation·DateApr 22, 2008

Your belly fat could be making you hungrier

Researchers at the University of Western Ontario discovered that abdominal fat tissue produces a hormone called Neuropeptide Y (NPY), which stimulates fat cell production. This novel finding may lead to new therapeutic targets for combating obesity, including the development of a simple blood test to detect increased levels of NPY.

SourceUniversity of Western Ontario·JournalThe FASEB Journal·DateApr 16, 2008

Procedure developed at Yale creates new bone

A new technique developed at Yale School of Medicine promotes rapid bone formation by removing bone marrow and injecting a hormone, offering a promising alternative to current treatments for weakened or fractured bones. The study, conducted in mice, shows that this procedure creates new bone tissue with improved biomechanical properties.

SourceYale University·JournalTissue Engineering·DateFeb 14, 2008

Researchers' discovery may lead to hypertension treatment

Researchers at Cornell University have identified a hormone in human urine that can safely reduce sodium levels and treat hypertension. The discovery was made possible by a new technique developed by Frank Schroeder, which allows for the analysis of complex mixtures of small molecules.

SourceCornell University·JournalProceedings of the National Academy of Sciences·DateNov 8, 2007

Hunger hormone fights aging in the thymus

Research suggests that ghrelin improves thymic mass and T cell output with increased diversity of the TCR repertoire in mice, highlighting its potential as a therapeutic approach to boost immune function in elderly or immunocompromised individuals.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateSep 6, 2007

Adults who go to bed lonely get stress hormone boost next morning

A study by Northwestern University found that older adults who go to bed feeling lonely, sad, or overwhelmed have elevated levels of cortisol the next morning. This morning cortisol boost can help regulate hormone levels and facilitate positive social experiences, potentially mitigating health problems associated with chronic stress.

SourceNorthwestern University·JournalProceedings of the National Academy of Sciences·DateOct 30, 2006

Black tea soothes away stress

A study by University College London researchers found that black tea consumption reduced cortisol levels and blood platelet activation after stressful events. The study, published in Psychopharmacology, suggests that drinking black tea may speed up recovery from daily stresses.

SourceUniversity College London·JournalPsychopharmacology·DateOct 4, 2006